UI Hospitals and Clinics
Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Participants in this research study have been diagnosed with a type of soft tissue sarcoma called liposarcoma that has spread to other parts of the body or is not able to be removed with surgery. This research study is being performed at about 8 clinics across the United States and approximately 38 people will participate. The purpose of the study is to see if the study drug pazopanib is safe and effective with subjects with liposarcoma.
Mohammed Milhem, 319-356-2324
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.